Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
SUBSCRIBE
Global Market Bulletin
  • Home
  • Stock Market News
  • Investing
  • Economy
  • CEO Interviews
  • Contact Us
No Result
View All Result
Global Market Bulletin
No Result
View All Result
Home Stock Market News

Top 10 Cheap Large-Cap Stocks Under $100 to Buy Now

by Global Market Bulletin
May 17, 2026
in Stock Market News
0
Top 10 Cheap Large-Cap Stocks Under $100 to Buy Now

Top 10 Cheap Large-Cap Stocks Under $100 to Buy Now

55
SHARES
119
VIEWS
Share on FacebookShare on Twitter

7. Microchip Technology Inc. (NASDAQ:MCHP)

Microchip Technology Inc. (NASDAQ: MCHP) lands at No. 7 among the best large-cap stocks to buy under $100, and this name brings investors straight into the semiconductor conversation. Trading at $93.85, down 3.29% based on the provided data, Microchip is not the loudest chip stock in the market, but it plays an important role in smart, connected, and secure embedded control solutions. For investors searching for semiconductor stocks under $100, AI stocks, data center stocks, large-cap technology stocks, chip stocks to buy, and best tech stocks under $100, Microchip offers a more grounded semiconductor story tied to microcontrollers, analog products, connectivity, memory, and design wins across high-growth end markets.

You might also like

5 Most Profitable Energy Stocks to Buy in 2026

10 Most Profitable Energy Stocks to Buy in 2026

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

On May 7, Microchip reported fiscal fourth-quarter 2026 net sales of $1.311 billion, up 35.1% year-over-year. The company also posted GAAP earnings per share of $0.21 and non-GAAP earnings per share of $0.57, exceeding prior guidance. That matters because the semiconductor industry has been working through inventory corrections, demand normalization, and shifting customer order patterns. When a chip company delivers results above guidance and points to improving demand, investors tend to pay attention.

For the full fiscal year 2026, Microchip generated net sales of $4.713 billion, up 7.1%. The company posted GAAP net income of $118.8 million, or $0.22 per diluted share, and non-GAAP net income of $933.9 million, or $1.64 per diluted share. The wide gap between GAAP and non-GAAP earnings is something investors should always examine carefully, but the broader message is clear: Microchip returned to stronger revenue growth and showed that its recovery plan is gaining traction.

One of the most important parts of Microchip’s update was its inventory reduction. The company reduced inventory by $320.9 million from its peak in late 2024, bringing days of inventory down to 185 days. In the semiconductor business, inventory is not a boring accounting detail. It is often one of the biggest signals of where the cycle is headed. Too much inventory can pressure pricing, production schedules, margins, and cash flow. Lower inventory can suggest that customer demand and internal production levels are getting healthier. Microchip’s inventory progress therefore supports the idea that the company is moving beyond the worst of its recent correction.

The company also returned $984.0 million to shareholders through dividends. That is a meaningful figure for investors looking for large-cap technology companies that combine cyclical recovery with capital returns. Many semiconductor stocks are valued heavily on growth potential, but shareholder returns can help support investor confidence, especially during periods when the market is debating whether chip demand is sustainable or too cyclical.

Microchip’s improving outlook is also tied to demand conditions, customer inventory normalization, and design wins in data center and AI applications. This part of the story is important for SEO and investor interest because artificial intelligence has changed the market’s perception of semiconductor demand. While the most famous AI chip names usually get the headlines, the AI ecosystem is broader than GPUs alone. Data centers need power management, connectivity, timing, control systems, microcontrollers, sensors, and analog components. Microchip’s portfolio touches several of these areas, making it part of the wider AI infrastructure and embedded systems supply chain.

For fiscal first-quarter 2027, Microchip expects the momentum to continue. The company forecast a net sales midpoint of $1.456 billion, representing an 11% sequential increase. Non-GAAP gross margins are expected to range from 62.25% to 63.25%, while non-GAAP EPS is expected to rise to a range of $0.67 to $0.71. The company also expects to manage full-year capital expenditures at around $100 million. That combination of higher sequential sales, strong gross margin expectations, and controlled capital spending could support operating leverage if demand continues to improve.

Microchip designs, develops, manufactures, and markets mixed-signal microcontrollers, development tools, analog and interface products, timing and connectivity devices, and memory products. The trivia here is that embedded chips are often invisible to ordinary consumers, but they are everywhere in modern life. They can be found in industrial machines, automobiles, home appliances, communications equipment, medical devices, data centers, and connected systems. That makes Microchip less glamorous than some high-profile AI semiconductor names, but potentially more diversified than investors may initially realize.

For long-term investors studying best large-cap stocks under $100, Microchip offers a semiconductor recovery angle without relying entirely on hype. The risk is that the chip industry remains cyclical and can be sensitive to inventory, pricing, and end-market demand. The opportunity is that Microchip appears to be moving into a better demand environment while improving factory utilization and benefiting from design wins tied to AI and data center applications. In a market where investors are searching for tech stocks that still trade below $100, Microchip remains a strong candidate to watch.

Click next to see the following stock...

Page 4 of 5
Prev1...345Next
Tags: Arch Capital Group Ltd. (NASDAQ:ACGL)Crown Castle Inc. (NYSE:CCI)Daily NewsletterGuardant Health Inc. (NASDAQ:GH)HeadlineMicrochip Technology Inc. (NASDAQ:MCHP)NASDAQ:ACGLNASDAQ:GHNASDAQ:MCHPNYSE:CCINYSE:VTRTop 10 Cheap Large-Cap Stocks Under $100 to Buy NowVentas Inc. (NYSE:VTR)Yahoo Finance
Share22Tweet14

Global Market Bulletin

Global Market Bulletin is a leading provider of stock market updates, economic news, and personalized investing guides. Our team brings you the latest global financial information to help you make smart investment decisions. About the Editorial Team Our editorial team consists of financial experts and seasoned market analysts who bring decades of experience to our coverage. With a commitment to unbiased reporting, our team ensures that every article is backed by thorough research and delivers accurate financial insights.

Recommended For You

5 Most Profitable Energy Stocks to Buy in 2026

by Global Market Bulletin
June 12, 2026
0
5 Most Profitable Energy Stocks to Buy in 2026

In this article, we break down the 5 Most Profitable Energy Stocks to Buy in 2026. For investors looking for the complete list, you can explore our full...

Read moreDetails

10 Most Profitable Energy Stocks to Buy in 2026

by Global Market Bulletin
June 12, 2026
0
10 Most Profitable Energy Stocks to Buy in 2026

In this article, we will take a look at the 10 Most Profitable Energy Stocks to Buy in 2026. Every market cycle has its surprise winner, and in...

Read moreDetails

Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

by Global Market Bulletin
June 6, 2026
0
Is Capricor Therapeutics (CAPR) a Smart Biotech Stock to Buy Before Its Next Catalyst?

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

by Global Market Bulletin
June 6, 2026
0
Here’s What Makes ImmunityBio (IBRX) a High-Upside Biotech Stock Investors Should Watch Closely

We recently published our article Top 5 Heavily Shorted Small-Cap and Mid-Cap Stocks to Buy Today. To read the full story, you can go directly to  Top 10...

Read moreDetails

Browse by Category

  • CEO Interviews
  • Economy
  • Investing
  • Stock Market News
  • Uncategorized

QUICK LINKS

  • Stock Market News
  • Investing
  • Economy
  • Contact Us
  • About Global Market Bulletin
  • Editorial Policy – Global Market Bulletin
  • Our Editorial Team

RECENT POSTS

  • 5 Most Profitable Energy Stocks to Buy in 2026
  • 10 Most Profitable Energy Stocks to Buy in 2026
  • Here’s What Makes Iovance Biotherapeutics (IOVA) a Smart Long-Term Buy

GET EMAIL MARKET UPDATES

Subscribe to our mailing list to receives daily updates direct to your inbox!
  • Privacy Policy
  • Terms and Conditions

© 2022 Global Market Bulletin. All Rights Reserved.

No Result
View All Result
  • Home
  • Stock Market News
  • Investing
  • Economy

© 2022 Global Market Bulletin. All Rights Reserved.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?